TECH OFFER

Australian Bush Bioactives with Potent Non-Steroidal Anti-Inflammatory Activity

KEY INFORMATION

TECHNOLOGY CATEGORY:
Healthcare - Pharmaceuticals & Therapeutics
TECHNOLOGY READINESS LEVEL (TRL):
LOCATION:
Australia
ID NUMBER:
TO116929

TECHNOLOGY OVERVIEW

The significance of this project is the potential to develop a new topical, non-steroidal anti-inflammatory treatment for dermatitis and psoriasis. Compounds in development are unrelated to those in current clinical use, possibly with a novel mechanism of action and improved safety profile.

Topical steroids are widely used in the management of inflammatory skin conditions such as dermatitis and psoriasis. While topical steroids therapies are generally effective and well tolerated when used at low strengths and on a short-term basis, the need to use more potent steroids on a more long term-basis in more severe disease can have undesirable side effects.

The limitations of these therapies, particularly in terms of their side-effect profiles, has driven the ongoing search for new drug entities potentially with novel mechanisms of action and improved safety profiles.

TECHNOLOGY FEATURES & SPECIFICATIONS

Novel compounds of the clerodane furanoditerpenoid type have been extracted and isolated from the native Australian plant, Dodonea polyandra.

Using a well-established animal model of skin inflammation we have demonstrated compounds have anti-inflammatory activity.

This activity is comparable to that seen with commonly used steroidal anti-inflammatory agents (including hydrocortisone and betamethasone) in the same model.

In addition, initial work has indicated the compounds have a different mechanism of action from other commonly used non-steroidal anti-inflammatory agents.

POTENTIAL APPLICATIONS

Compounds and/or botanical extracts can be used the following three markets:

  • Therapeutic anti-inflammatory
  • Complementary and alternative therapies
  • Natural personal care

Market Trends & Opportunities

The team is seeking co-development partners and technology licensees for the development of therapeutic anti-inflammatory pharmaceuticals, complementary and alternative therapies and personal care products.

Our current focus is the development of topical formulations for treatment of dermatitis and psoriasis however compound could also be made available for testing on other animal models to interested parties.

Unique Value Proposition

Australian Indigenous native plant bioactive extracts and compounds with potent non-steroidal anti-inflammatory activity.

• Novel bioactives display non-steroidal anti-inflammatory activity
• Equivalent efficacy to corticosteroids
• Novel mechanism of action
• Safe, clear and odourless extract
• Socially, ethically and sustainable entrepreneurship project supporting Aboriginal homeland communities

RELATED TECH OFFERS
Cosmetic & Fragrance Applications of CaproGlu Bioadhesives
Leapfrogging Aquaculture Side-stream Wastage
Efficient & Sustainable Method for Algae-based Carotenoid
Using Natural Products to Improve Skin Microflora for Atopic Dermatitis
Sepsis Prediction Algorithm For Intensive Care
Encapsulation For Targeted Release Of Probiotics In Gut
Biodegradable, Organic Solvent-Free Nanoencapsulation of Hydrophobic Actives
Novel Analytical Pipelines for Gut Health Assessment
Drug Delivery Composition Comprising Polymerlipid Hybrid (PLH) Microparticles
Proprietary Probiotic Strain of Bifidobacterium longum for Infant Health